2001
DOI: 10.2460/ajvr.2001.62.496
|View full text |Cite
|
Sign up to set email alerts
|

Effect of centrally administered opioid receptor agonists on CSF and plasma oxytocin concentrations in dogs

Abstract: Results suggest that in male dogs, activation of centrally located mu and kappa receptors elicits an overall excitatory effect on neurons that regulate peripheral release of oxytocin, whereas activation of centrally located kappa receptors elicits an overall inhibitory effect on neurons that regulate central release. These results are in contrast to those reported for other species, in which opioids have a pronounced inhibitory effect on release of oxytocin from the neurohypophysis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…In response to i.v. cholecystokinin, oxytocin is released into the blood and in the hypothalamus (79), but several other agents affect release differentially: for instance, in dogs, opioids stimulate peripheral secretion but suppress central secretion (80). Hyperosmotic stimuli increase oxytocin release from both dendrites and nerve terminals in rats, but on different time scales; dendritic release is increased as plasma concentrations fall (2).…”
Section: Central and Peripheral Release Of Oxytocinmentioning
confidence: 99%
“…In response to i.v. cholecystokinin, oxytocin is released into the blood and in the hypothalamus (79), but several other agents affect release differentially: for instance, in dogs, opioids stimulate peripheral secretion but suppress central secretion (80). Hyperosmotic stimuli increase oxytocin release from both dendrites and nerve terminals in rats, but on different time scales; dendritic release is increased as plasma concentrations fall (2).…”
Section: Central and Peripheral Release Of Oxytocinmentioning
confidence: 99%
“… Experimental paradigms. These range from the examination of baseline levels of central and peripheral OT [ 13 , 21 ], and levels following some environmental stimulus such as light [ 22 ], and stressors [ 7 , 23 ], to examinations of concentrations after manipulation of OT levels by osmotic stimulation [ 9 ], drug administration [ 24 26 ], or the administration of intranasal [ 14 , 27 ] or intraperitoneal [ 27 ] OT. Since the pharmacokinetics of OT seem to exhibit quite complex, time-dependent patterns [ 9 ], there is a possibility that differences in experimental designs account for differences in correlations between studies.…”
Section: Methodsmentioning
confidence: 99%